Filing Details
- Accession Number:
- 0001209191-20-042007
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-07-09 17:43:05
- Reporting Period:
- 2020-07-07
- Accepted Time:
- 2020-07-09 17:43:05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1623526 | Stoke Therapeutics Inc. | STOK | Pharmaceutical Preparations (2834) | 471144582 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1790807 | A. Robin Walker | C/O Stoke Therapeutics, Inc. 45 Wiggins Avenue Bedford MA 01730 | Chief Legal Officer, Cco & Sec | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-07-07 | 941 | $22.50 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- Includes 941 shares of Common Stock acquired under the issuer's employee stock purchase plan on June 30, 2020.
Billionaire Hedge Funds
